
Agivog 0.3 Tablet
Marketer
Jubilant Life Sciences
Salt Composition
Voglibose (0.3mg)
Overview Agivog 0.3 Tablet
Diabetol 0.3mg tablets are indicated for the management of type 2 diabetes. This medication aids in postprandial blood glucose regulation, employed when dietary modifications and other antidiabetic agents prove insufficient to achieve glycemic control. Diabetol 0.3mg tablets should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize blood sugar management. Discontinuation should only occur under medical supervision; abrupt cessation may result in hyperglycemia and potentially serious complications, including renal impairment and visual disturbances. This medication forms part of a comprehensive treatment plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include abdominal discomfort, flatulence, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabetol 0.3mg tablets themselves do not induce hypoglycemia, concomitant use with other antidiabetic medications (particularly insulin or sulfonylureas) may increase the risk. Glucose should be used to treat hypoglycemic episodes; sucrose is ineffective in this context. Prior to commencing treatment, inform your physician of any hepatic or renal dysfunction. This medication is contraindicated in patients with inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating women should seek medical counsel before use. Comprehensive disclosure of all concurrently used medications is crucial for safe medication management. Excessive alcohol consumption should be avoided due to the increased risk of hypoglycemia.
Primary Ingredients of Agivog 0.3 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Agivog 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Agivog 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Agivog 0.3 Tablet should be taken on an empty stomach.
Common Side effects of Agivog 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Agivog 0.3 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Agivog 0.3 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Agivog 0.3 Tablet works:
Agivog 0.3mg tablets help manage diabetes by blocking the action of intestinal enzymes that digest complex carbohydrates. This action reduces post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Agivog 0.3 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Agivog 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Agivog 0.3 Tablet while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Agivog 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Agivog 0.3 Tablet cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Agivog 0.3mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Agivog 0.3 Tablet :
Omit a missed dose of Agivog 0.3 Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Agivog 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
